Key Financial Data Of Group

ONO PHARMACEUTICAL CO., LTD. - Filing #7587134

Concept As at
2022-09-30
2022-07-01 to
2022-09-30
2022-04-01 to
2022-09-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-09-30
2021-07-01 to
2021-09-30
2021-04-01 to
2021-09-30
Key financial data of group
Business results of group
Revenue
109,979,000,000 JPY
216,701,000,000 JPY
361,361,000,000 JPY
86,714,000,000 JPY
174,077,000,000 JPY
Profit (loss) before tax
81,019,000,000 JPY
105,025,000,000 JPY
59,231,000,000 JPY
Profit (loss), attributable to owners of parent
32,862,000,000 JPY
62,339,000,000 JPY
80,519,000,000 JPY
22,216,000,000 JPY
46,290,000,000 JPY
Comprehensive income
62,263,000,000 JPY
79,606,000,000 JPY
52,252,000,000 JPY
Equity attributable to owners of parent
704,518,000,000 JPY
655,906,000,000 JPY
672,634,000,000 JPY
Total assets
805,008,000,000 JPY
739,203,000,000 JPY
771,487,000,000 JPY
Basic earnings (loss) per share
67.30
127.67
162.19
44.51
92.74
Diluted earnings (loss) per share
67.30
127.66
162.16
44.50
92.73
Ratio of owners' equity to gross assets
0.875 xbrli:pure
0.887 xbrli:pure
0.872 xbrli:pure
Cash flows from (used in) operating activities
80,977,000,000 JPY
61,829,000,000 JPY
40,369,000,000 JPY
Cash flows from (used in) investing activities
-37,925,000,000 JPY
6,038,000,000 JPY
-5,385,000,000 JPY
Cash flows from (used in) financing activities
-15,065,000,000 JPY
-60,237,000,000 JPY
-14,968,000,000 JPY
Cash and cash equivalents
97,752,000,000 JPY
69,112,000,000 JPY
81,117,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.